- Sarepta Therapeutics entered a settlement agreement with Regenxbio, the University of Pennsylvania Trustees, and Catalent.
Sarepta Therapeutics said it entered a settlement agreement with Regenxbio, the University of Pennsylvania Trustees, and Catalent. The initial announcement did not disclose financial or other terms.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.